advanc
technolog
use
polymerasechain
reaction
allow
increas
recognit
viral
respiratori
infect
includ
pneumonia
coinfect
describ
sever
respiratori
virus
especi
influenza
outcom
viral
pneumonia
includ
case
coinfect
well
describ
observ
cohort
studi
conduct
describ
hospit
patient
viral
pneumonia
includ
coinfect
clinic
outcom
predictor
mortal
patient
admit
march
novemb
posit
respiratori
viru
panel
rvp
radiograph
find
pneumonia
within
h
index
rvp
includ
corespiratori
infect
cri
defin
organ
identif
respiratori
specimen
within
day
index
rvp
predictor
inhospit
mortal
univari
analysi
evalu
multivari
model
patient
viral
pneumonia
major
immunocompromis
total
patient
found
cri
bacteri
cri
viral
cri
hsv
cmv
occur
patient
fungal
cri
less
common
mani
patient
requir
mechan
ventil
vasopressor
support
overal
inhospit
mortal
high
readmiss
common
sever
patient
rehospit
within
day
discharg
predictor
inhospit
mortal
multivari
regress
includ
sever
ill
factor
stemcel
transplant
identif
multipl
respiratori
virus
conclus
hospit
mortal
high
among
adult
patient
viral
pneumonia
patient
multipl
respiratori
virus
identifi
may
higher
risk
medicin
abbrevi
apach
acut
physiolog
chronic
health
evalu
cmv
cytomegaloviru
cri
corespiratori
infect
emr
electron
medic
record
hmpv
human
metapneumoviru
hsv
herp
simplex
viru
icu
intens
care
unit
lo
lengthofstay
np
nasopharyng
piv
parainfluenza
viru
rci
respiratori
coinfect
rsv
respiratori
syncyti
viru
rvp
respiratori
viru
panel
editor
krisztian
banyai
v
iral
pneumonia
lower
respiratori
tract
infect
increasingli
recogn
adult
patient
includ
critic
ill
appear
viral
lower
respiratori
tract
infect
communityacquir
account
signific
etiolog
mechan
ventil
patient
sever
communityacquir
pneumonia
bacterialvir
coinfect
best
describ
influenza
long
histori
bacteri
infect
occur
concurr
shortli
influenza
ill
date
back
influenza
pandem
fatal
case
found
due
coinfect
base
autopsi
find
recent
influenza
pandem
complic
bacteri
pneumonia
hospit
critic
ill
patient
commonli
isol
coinfect
bacteri
organ
influenza
streptococcu
pneumonia
staphylococcu
aureu
pyogen
haemophilu
influenza
influenza
season
equal
associ
lower
mortal
potenti
relat
differ
virul
factor
unknown
reason
bacteri
coinfect
limit
influenza
describ
numer
respiratori
virus
includ
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
rhinoviru
adenoviru
human
metapneumoviru
hmpv
advanc
technolog
allow
increas
recognit
viral
pathogen
diagnos
viral
respiratori
infect
includ
pneumonia
sever
mechan
viral
respiratori
infect
may
predispos
patient
bacteri
coinfect
investig
includ
virusinduc
alter
epitheli
cell
impair
immun
respons
enhanc
bacteri
colon
util
new
diagnost
technolog
may
possibl
better
describ
clinic
aspect
viral
pneumonia
interact
infect
organ
purpos
studi
describ
hospit
adult
patient
viral
pneumonia
includ
possibl
coinfect
clinic
outcom
viral
pneumonia
defin
identif
respiratori
viru
rvp
new
progress
radiograph
infiltr
within
h
respiratori
coinfect
rci
defin
identif
respiratori
pathogen
specimen
obtain
within
h
index
rvp
rci
stratifi
bacteri
viral
hsv
cmv
fungal
rci
includ
mycobacteria
spp
pneumocysti
jiroveci
candida
spp
isol
respiratori
specimen
exclud
rci
consider
immunocompromis
statu
defin
diagnosi
hiv
activ
malign
stem
cell
transplant
receiv
chemotherapi
solid
organ
transplant
current
receiv
immunosuppress
therapi
prednison
mgday
least
day
equival
determin
apach
ii
score
base
physic
laboratori
find
day
index
rvp
obtain
charlson
comorbid
index
use
summ
score
underli
diseas
state
electron
medic
record
emr
queri
use
acquir
patient
inform
possibl
manual
chart
review
use
valid
supplement
emr
queri
inform
regard
rvp
includ
time
collect
report
type
specimen
patient
locat
time
collect
result
find
obtain
intern
databas
addit
avail
aerob
anaerob
bacteri
cultur
evalu
avail
base
emr
queri
urin
antigen
legionella
directfluoresc
antibodi
pneumocysti
jiroveci
clostridium
difficil
toxin
assay
also
evalu
vitro
suscept
evalu
report
per
institut
practic
primari
endpoint
evalu
inhospit
mortal
secondari
endpoint
includ
hospit
lengthofstay
lo
intens
care
unit
icu
admiss
readmiss
rate
day
index
hospit
descript
statist
use
describ
overal
popul
adult
patient
viral
pneumonia
univari
analys
perform
compar
survivor
nonsurvivor
categor
variabl
compar
use
chi
squar
fisher
exact
test
appropri
continu
variabl
compar
use
mannwhitney
u
test
test
p
valu
consid
signific
multivari
logist
regress
analysi
use
determin
factor
independ
associ
inhospit
mortal
variabl
p
valu
univari
analys
enter
multivari
model
use
backward
stepwis
approach
statist
analys
perform
use
spss
version
chicago
il
total
adult
patient
identifi
viral
pneumonia
studi
fig
demograph
clinic
characterist
summar
tabl
slightli
women
men
patient
caucasian
major
patient
immunocompromis
activ
malign
common
etiolog
follow
solid
organ
transplant
nearli
patient
least
chronic
comorbid
condit
sever
diabet
mellitu
chronic
kidney
diseas
chronic
obstruct
pulmonari
diseas
commonli
identifi
comorbid
condit
patient
hospit
day
prior
index
admiss
patient
critic
ill
sever
ill
also
high
illustr
median
apach
ii
score
major
patient
mechan
ventil
sever
requir
vasopressor
support
common
virus
identifi
influenza
rhinoviru
enteroviru
piv
rsv
tabl
sever
n
patient
multipl
virus
identifi
rvp
fig
rsv
rhinoviru
enteroviru
influenza
coronaviru
commonli
identifi
among
patient
multipl
virus
identifi
rvp
patient
multipl
virus
immunocompromis
activ
malign
stemcel
transplant
lung
transplant
patient
aid
among
patient
influenza
n
receiv
oseltamivir
n
receiv
investig
intraven
zanamivir
inhal
ribavirin
administ
n
patient
rsv
n
patient
overal
indic
inhal
ribavirin
includ
hmpv
piv
rhinovirusenteroviru
total
patient
viral
pneumonia
identifi
rci
bacteri
coinfect
common
tabl
patient
adenoviru
multipl
virus
identifi
rvp
like
bacteri
rci
fig
patient
viral
pneumonia
due
piv
rsv
influenza
least
like
bacteri
rci
n
patient
went
subsequ
bacteri
rci
occur
day
index
rvp
report
date
onethird
patient
n
rci
either
hsv
cmv
coinfect
patient
adenoviru
pneumonia
like
cmv
rci
rate
cmv
rci
differ
much
among
rvp
viru
type
total
patient
identifi
fungal
rci
n
immunocompromis
n
activ
malign
aspergillu
sp
common
fungal
organ
seen
adv
multivari
model
use
evalu
inhospit
mortal
accept
hosmerlemeshow
goodnessof
fit
test
p
fit
data
well
area
receiv
oper
characterist
curv
tabl
variabl
identifi
associ
inhospit
mortal
includ
primarili
sever
ill
factor
intens
care
unit
icu
admiss
apach
ii
score
vasopressor
requir
stemcel
transplant
aor
p
identif
multipl
virus
rvp
aor
p
also
associ
mortal
overal
inhospit
mortal
high
patient
admit
icu
inhospit
mortal
higher
among
icu
patient
activ
malign
compar
icu
patient
respect
p
icu
lengthofstay
variabl
median
day
iqr
total
hospit
lengthofstay
median
day
iqr
readmiss
common
sever
patient
rehospit
within
discharg
studi
describ
hospit
adult
patient
viral
pneumonia
assess
factor
associ
increas
inhospit
mortal
identif
multipl
virus
rvp
stemcel
transplant
icu
admiss
apach
ii
score
requir
vasopressor
significantli
associ
inhospit
mortal
multivari
model
sever
patient
n
rci
bacteri
n
patient
viral
pneumonia
due
adenoviru
multipl
respiratori
virus
like
bacteri
rci
increas
recognit
virus
pathogen
lower
respiratori
tract
infect
pneumonia
alter
landscap
ill
studi
sever
ill
characterist
identifi
primari
factor
associ
inhospit
mortal
among
patient
viral
pneumonia
interestingli
identif
multipl
respiratori
virus
also
associ
increas
mortal
potenti
explan
find
host
characterist
enabl
infect
multipl
respiratori
virus
may
lead
wors
outcom
find
may
surrog
marker
immunocompromis
debilit
statu
patient
thu
increas
risk
death
howev
also
possibl
coinfect
multipl
virus
lead
pathogen
detriment
respiratori
process
bacteri
coinfect
found
associ
inhospit
mortal
studi
choi
et
al
previous
found
differ
mortal
icu
patient
sever
bacteri
viral
pneumonia
respect
pure
bacteri
pneumonia
compar
group
studi
direct
comparison
outcom
made
viral
bacteri
pneumonia
result
suggest
clinic
outcom
viral
pneumonia
may
substanti
impact
presenc
coinfect
bacteria
howev
antibacteri
therapi
popul
thoroughli
evalu
appropri
would
like
impact
clinic
outcom
patient
bacteri
rci
bacteri
rci
occur
patient
aureu
streptococci
commonli
identifi
organ
prospect
studi
mechan
ventil
patient
sever
communityacquir
pneumonia
karhu
et
al
pneumonia
frequent
identifi
coinfect
bacteri
pathogen
n
among
patient
mix
viralbacteri
pneumonia
addit
studi
found
frequent
bacteri
coinfect
patient
pure
viral
infect
compar
mix
viralbacteri
infect
studi
limit
communityacquir
infect
may
account
dispar
howev
studi
also
report
lower
rate
bacteri
coinfect
addit
unlik
higher
incid
healthcarerel
infect
would
explain
lower
rate
bacteri
coinfect
observ
sever
limit
studi
recogn
first
retrospect
design
allow
determin
caus
mortal
furthermor
antibacteri
administr
respiratori
cultur
obtain
evalu
could
impact
rate
bacteri
rci
seen
second
patient
transfer
outsid
hospit
may
addit
infecti
process
identifi
cultur
taken
outsid
hospit
system
case
coinfect
may
miss
fals
decreas
rate
observ
third
viral
shed
may
occur
sever
day
week
initi
respiratori
viru
infect
especi
among
immunocompromis
patient
studi
classifi
viral
pneumonia
base
index
rvp
report
date
radiograph
evid
pneumonia
possibl
patient
initi
viral
infect
occur
day
identif
rvp
concomit
process
detect
imag
case
bacteri
rci
would
classifi
subsequ
infect
fourth
case
studi
occur
period
singl
institut
viral
epidemiolog
site
timefram
may
repres
season
locat
final
due
constraint
rvp
use
may
identifi
possibl
viral
infect
bocaviru
respiratori
virus
continu
frequent
identifi
hospit
patient
new
technolog
push
diagnost
abil
forward
studi
describ
hospit
adult
patient
viral
pneumonia
factor
associ
inhospit
mortal
identif
multipl
respiratori
virus
sever
factor
describ
sever
ill
associ
inhospit
mortal
multivari
model
recognit
multipl
virus
poor
prognost
indic
interest
increas
abil
recogn
viral
pathogen
find
could
simpli
result
improv
diagnost
howev
may
also
indic
host
factor
allow
simultan
infect
multipl
respiratori
virus
studi
patient
viral
pneumonia
bacteri
rci
use
antibacteri
set
evalu
futur
research
focu
role
empir
antibacteri
use
patient
viral
infect
identifi
addit
procalcitonin
shown
use
differenti
viral
infect
bacteri
could
prove
use
conjunct
identif
respiratori
viru
popul
conclus
studi
add
grow
bodi
literatur
regard
epidemiolog
viral
pneumonia
adult
patient
illustr
high
morbid
mortal
associ
viral
pneumonia
adult
patient
addit
studi
suggest
identif
multipl
infect
respiratori
virus
neg
prognost
indic
illustr
associ
inhospit
mortal
continu
advanc
diagnost
technolog
enabl
thorough
evalu
respiratori
infect
investig
role
virus
play
pneumonia
may
unclos
answer
regard
patient
risk
factor
outcom
viral
pneumonia
